Hester Biosciences Ltd.
NSE: HESTERBIO | BSE: 524669
₹1,993.20
₹31.60
(1.61%)
As on 08-Jun-2026 10:58IST
Market cap
₹1,671 Cr
Revenue (TTM)
₹333 Cr
P/E Ratio
30
P/B Ratio
4.6
Div. Yield
0.6 %
Quality Score
5/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹56 Cr
-
ROE
9.5 %
-
ROCE
9.9 %
-
Industry P/E
37.28
-
EV/EBITDA
19.2
-
Debt to Equity
0.2
-
Book Value
₹423.5
-
EPS
₹63
-
Face value
10
-
Shares outstanding
8,506,865
10 Years Aggregate
CFO
₹378.20 Cr
EBITDA
₹538.37 Cr
Net Profit
₹288.94 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hester Biosciences
| 24.6 | 21.7 | 35.2 | 7.3 | 7.0 | -6.3 | 12.3 |
|
BSE Healthcare
| 8.7 | 1.8 | 8.4 | 9.2 | 24.6 | 13.7 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Hester Biosciences
| -33.1 | 64.5 | -18.6 | -29.2 | 50.0 | 17.7 | 24.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hester Biosciences
|
1,993.2 | 1,671.1 | 332.6 | 51.1 | 20.4 | 15.4 | 30 | 4.6 |
| 3,400.0 | 27,250.0 | 1,339.4 | 356.4 | 33.2 | 23.2 | 76.5 | 16.5 | |
| 3,010.9 | 37,200.8 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 35.2 | 8.2 | |
| 1,770.8 | 33,389.6 | 9,203.5 | 941.3 | 15.4 | 19.6 | 36.1 | 6.7 | |
| 2,216.0 | 34,833.2 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.1 | 8.4 | |
| 16,978.0 | 21,570.8 | 2,023.0 | 364.0 | 23.9 | 20.8 | 59.3 | 11.5 | |
| 2,738.5 | 1,689.8 | 501.2 | 48.0 | 10.4 | 15.3 | 35.1 | 5.1 | |
| 166.3 | 22,200.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 255.8 | 11,146.9 | 2,643.8 | 152.1 | 12.0 | 7.7 | 62.9 | 3.8 | |
| 1,896.1 | 31,200.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 146.5 | 6.3 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Companies with less institutional holdings
4 min read•By Jugal Harpalani
1 min read•By Research Desk
About Hester Biosciences
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines... for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucella abortus, contagious bovine pleuropneumonia, CCPP, and lumpy skin diseases; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutic treatment, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides seroprofiling kits; diagnostic labs for poultry flocks; and mastitis control programs for cattle; as well as engages in manufacturing and trading of goods. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India. Read more
-
Incorporated
1987
-
Chairman
Bhupendra Gandhi
-
Managing Director
Rajiv Gandhi
-
Headquarters
Mehsana, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Hester Biosciences
What is the current share price of Hester Biosciences Ltd Today?
The share price of Hester Biosciences Ltd is ₹1,993.20 (NSE) and ₹1,998.00 (BSE) as of 08-Jun-2026 10:58 IST. Hester Biosciences Ltd has given a return of 7% in the last 3 years.
What is the current PB & PE ratio of Hester Biosciences Ltd?
The P/E ratio of Hester Biosciences Ltd is 30.03 times as on 05-Jun-2026, a 19 discount to its peers’ median range of 37.28 times.
The P/B ratio of Hester Biosciences Ltd is 4.64 times as on 05-Jun-2026, a 9 discount to its peers’ median range of 5.12 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
38.81
|
3.39
|
|
2024
|
62.57
|
4.05
|
|
2023
|
48.58
|
4.62
|
|
2022
|
58.75
|
8.88
|
|
2021
|
47.36
|
7.14
|
What is the 52 Week High and Low of Hester Biosciences Ltd?
The 52-week high and low of Hester Biosciences Ltd are Rs 2,350.00 and Rs 1,239.30 as of 08-Jun-2026.
What is the market cap of Hester Biosciences Ltd?
Hester Biosciences Ltd has a market capitalisation of ₹ 1,671 Cr as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Hester Biosciences Ltd?
Before investing in Hester Biosciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.